As PI3K mutations and AKT hyper-activation frequently occurs in cancers, our results suggest that these alterations may also favor TRF1 stability, telomere protection and telomere maintenance, a hallmark of cancer cells [20]. This evidence concerns the gene AKT1 and cancer.